Candesic advised on the acquisition and investment of Aesthetic Technology by Omni Partners By Candesic Ltd

Candesic advised on the acquisition and investment of Aesthetic Technology Ltd by Omni Partners LLP. 

We are proud to share our support on this deal that will accelerate ATL’s international expansion and product development into further medical treatment pathways. 

About

Candesic is a leading strategy consultancy head-quartered in London, serving private operators, investors, and public sector organisations.

Privacy

Privacy Policy

News & Publications

Business Analyst class of 2023
We are thrilled to introduce to you our Business Analyst class of 2023. Let`s welcome Jawad Barbar, Campbell Foubister, Zeynep Kubaç, Iham Kasem, Phaidon Theologites and Buzz Gilks! All of you bring a unique set of skills and perspectives to our team, and we are excited to see how you will contribute to Candesic. We are lucky to have you on board!

Candesic`s Dr Joe Taylor and Dr Leonid Shapiro published in the latest PharmaTimes
Candesic`s Dr Joe Taylor and Dr Leonid Shapiro discuss in PharmaTimes the significant opportunities, and the challenges, in the use of AI for drug discovery. As we continue to discover the potential of this powerful form of research, it is crucial to ensure correct safeguards.

Marc Kitten participating in the PE Insights 2023 conference
We're looking forward to participate in the 2023 Private Equity Insights Conference in London on the 22nd of September! Candesic partner Marc Kitten will be joining industry leaders and experts to discuss current trends and the overall environment for private equity in the UK. We hope to see you there! Click on the link to find out more.

© Candesic 2023